Clinical Trial: Evaluating the Efficacy and Safety of Tranexamic Acid in Reducing Perioperative Bleeding During Recurrent Hypospadias Repair.

U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07778992) titled 'Evaluating the Efficacy and Safety of Tranexamic Acid in Reducing Perioperative Bleeding During Recurrent Hypospadias Repair.' on Aug. 08.

Brief Summary: This study aims to fill that gap by evaluating the efficacy and safety of intravenous TXA in children undergoing redo hypospadias surgery, potentially establishing a new standard of care

Study Start Date: March 01

Study Type: INTERVENTIONAL

Condition: Perioperative Bleeding During Recurrent Hypospadias Repair

Intervention: DRUG: single intravenous (IV) bolus dose of tranexamic acid (TXA) at 15 mg/kg (maximum dose 1000 mg)

single intravenous (IV) bolus dose of tranexamic acid...